Granulocyte Chemotactic Protein 2 (CXCL6) Human Recombinant
Granulocyte Chemotactic Protein 2 (CXCL6) Bovine Recombinant
Recombinant Bovine Granulocyte Chemotactic Protein 2 (CXCL6), produced in E. coli, is a non-glycosylated polypeptide chain composed of 76 amino acids with an approximate molecular weight of 8.0 kDa. The purification of GCP2 is achieved using proprietary chromatographic methods.
Escherichia Coli.
Sterile Filtered White lyophilized (freeze-dried) powder.
Key Biological Properties: CXCL6 is chemotactic for neutrophil granulocytes and has strong antibacterial activity against both Gram-positive and Gram-negative bacteria .
Expression Patterns and Tissue Distribution: CXCL6 is expressed in various tissues, including bronchial epithelial cells, spleen, olfactory zone of nasal mucosa, cartilage tissue, and islet of Langerhans beta cells . It is also found in the right lobe of the liver, cervix, endothelial cells of lymphatic vessels, and trachea .
Primary Biological Functions: CXCL6 plays a crucial role in recruiting neutrophils to sites of inflammation, thereby contributing to non-specific immunity . It also has angiogenic properties and promotes tissue repair .
Role in Immune Responses and Pathogen Recognition: CXCL6 is involved in the immune response by attracting neutrophils to infection sites, enhancing the body’s ability to fight off pathogens .
Mechanisms with Other Molecules and Cells: CXCL6 exerts its effects by binding to chemokine receptors CXCR1 and CXCR2 . This interaction triggers downstream signaling pathways that lead to chemotaxis and activation of neutrophils .
Binding Partners and Downstream Signaling Cascades: The binding of CXCL6 to CXCR1 and CXCR2 activates G protein-coupled receptor signaling pathways, leading to various cellular responses, including chemotaxis and activation of immune cells .
Regulatory Mechanisms Controlling Expression and Activity: The expression of CXCL6 is regulated by various factors, including cancer-related genes and interleukin family members . These factors can promote the abnormal secretion of CXCL6, which in turn affects tumor growth and metastasis .
Transcriptional Regulation and Post-Translational Modifications: Specific transcription factors and kinases, such as RELA, NFKB1, LCK, and PAK2, play a role in the transcriptional regulation of CXCL6 . Post-translational modifications, such as phosphorylation, may also influence its activity .
Biomedical Research: CXCL6 is a potential therapeutic target for inflammation and cancer due to its role in recruiting neutrophils and promoting angiogenesis .
Diagnostic Tools and Therapeutic Strategies: Elevated levels of CXCL6 can serve as biomarkers for diseases such as idiopathic pulmonary fibrosis and various cancers . Therapeutic strategies targeting CXCL6 and its receptors are being explored for their potential to modulate immune responses and inhibit tumor progression .